100 related articles for article (PubMed ID: 26784362)
1. SNPing away to individualize induction therapy for acute myelogenous leukemia.
Kaplan JB; Altman JK; Platanias LC
Leuk Lymphoma; 2016; 57(4):742-3. PubMed ID: 26784362
[No Abstract] [Full Text] [Related]
2. Decitabine as salvage therapy for primary induction failure of acute myeloid leukemia.
Niscola P; Neri B; Catalano G; Morino L; Giovannini M; Scaramucci L; Fratoni S; Noguera NI; Cordone I; de Fabritiis P
Acta Oncol; 2017 Aug; 56(8):1120-1121. PubMed ID: 28406054
[No Abstract] [Full Text] [Related]
3. [Acute myeloid leukemia with complete remission].
BERGSTROM I; LJUNGGREN H
Nord Med; 1950 Sep; 44(37):1482-3. PubMed ID: 14806944
[No Abstract] [Full Text] [Related]
4. [Efficacy analysis of CHAG priming regimen as induction therapy for newly diagnosed acute myelogenous leukemia].
Hao Q; Wei X; Yin Q; Mi R; Yuan F; Ai H; Wang P; Chen L; Song Y
Zhonghua Xue Ye Xue Za Zhi; 2015 Jan; 36(1):68-9. PubMed ID: 25641153
[No Abstract] [Full Text] [Related]
5. Invasive fungal diseases during first induction chemotherapy affect complete remission achievement and long-term survival of patients with acute myeloid leukemia.
Girmenia C; Micozzi A; Piciocchi A; Gentile G; Di Caprio L; Nasso D; Minotti C; Capria S; Cartoni C; Alimena G; Meloni G; Amadori S; Foà R; Venditti A
Leuk Res; 2014 Apr; 38(4):469-74. PubMed ID: 24534569
[TBL] [Abstract][Full Text] [Related]
6. NCCN Practice Guidelines for Acute Myelogenous Leukemia.
Appelbaum FR; Baer MR; Carabasi MH; Coutre SE; Erba HP; Estey E; Glenn MJ; Kraut EH; Maslak P; Millenson M; Miller CB; Saba HI; Stone R; Tallman MS;
Oncology (Williston Park); 2000 Nov; 14(11A):53-61. PubMed ID: 11195419
[No Abstract] [Full Text] [Related]
7. Homoharringtonine, aclarubicin and cytarabine (HAA) regimen as the first course of induction therapy is highly effective for acute myeloid leukemia with t (8;21).
Zhu HH; Jiang H; Jiang Q; Jia JS; Qin YZ; Huang XJ
Leuk Res; 2016 May; 44():40-4. PubMed ID: 26994850
[TBL] [Abstract][Full Text] [Related]
8. Etoposide in remission induction of adult acute myeloid leukemia.
Leoni F; Ciolli S; Patriarchi S; Morfini M; Rossi Ferrini P
Acta Haematol; 1990; 83(2):82-5. PubMed ID: 2106200
[TBL] [Abstract][Full Text] [Related]
9. Remission induction therapy for adults with acute myelogenous leukemia: towards the ICE age?
Bassan R; Barbui T
Haematologica; 1995; 80(1):82-90. PubMed ID: 7758997
[TBL] [Abstract][Full Text] [Related]
10. Postremission therapy for the younger adult patient with acute myelogenous leukemia: defining a role for transplantation.
Hurd DD
J Clin Oncol; 1993 Sep; 11(9):1636-8. PubMed ID: 8204125
[No Abstract] [Full Text] [Related]
11. Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome.
Keating MJ; Smith TL; Kantarjian H; Cork A; Walters R; Trujillo JM; McCredie KB; Gehan EA; Freireich EJ
Leukemia; 1988 Jul; 2(7):403-12. PubMed ID: 3164797
[TBL] [Abstract][Full Text] [Related]
12. Strategies for acute myelogenous leukemia.
Gale RP; Butturini A
Bone Marrow Transplant; 1991; 7 Suppl 2():58. PubMed ID: 1878721
[No Abstract] [Full Text] [Related]
13. Treatment of acute myelogenous leukemia.
Ghaddar H; Anderlini P; Estey E
N Engl J Med; 1995 Jun; 332(25):1717-8; author reply 1718-9. PubMed ID: 7760880
[No Abstract] [Full Text] [Related]
14. Transplantation of autologous peripheral blood progenitor cells procured after high-dose cytarabine-based consolidation chemotherapy for adults with secondary acute myelogenous leukemia in first remission.
Schiller G; Lee M; Paquette R; Sawyers C; Khoubian F; Territo M
Leuk Lymphoma; 1999 May; 33(5-6):475-84. PubMed ID: 10342575
[TBL] [Abstract][Full Text] [Related]
15. Post-remission treatment of acute myelogenous leukemia.
Löwenberg B
N Engl J Med; 1995 Jan; 332(4):260-2. PubMed ID: 7808494
[No Abstract] [Full Text] [Related]
16. Is there a role for postremission therapy in older adults with acute myelogenous leukemia (AML)?
Rowe JM
Leukemia; 2005 Aug; 19(8):1324-7. PubMed ID: 15944718
[No Abstract] [Full Text] [Related]
17. Remission induction by granulocyte colony-stimulating factor in hypoplastic acute myelogenous leukemia complicated by infection. A case report and review of the literature.
Takamatsu Y; Miyamoto T; Iwasaki H; Makino S; Tamura K
Acta Haematol; 1998; 99(4):224-30. PubMed ID: 9644302
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy versus transplantation: I. Acute myelogenous leukemia.
Gale RP; Butturini A
Haematologica; 1989; 74(1):1-4. PubMed ID: 2498172
[No Abstract] [Full Text] [Related]
19. Treatment of acute myelogenous leukaemia.
Löwenberg B
J Intern Med Suppl; 1997; 740():17-22. PubMed ID: 9350177
[TBL] [Abstract][Full Text] [Related]
20. Treatment of acute myelogenous leukemia.
Meisenberg B
N Engl J Med; 1995 Jun; 332(25):1718; author reply 1718-9. PubMed ID: 7619165
[No Abstract] [Full Text] [Related]
[Next] [New Search]
